The sheer volume of blood the NHS requires

NHS Blood and Transplant collects over one million units of whole blood per year in England and distributes over six thousand units every single day. This includes red blood cells for surgical and trauma patients, platelets for cancer patients undergoing chemotherapy and people with blood disorders, and plasma for patients with clotting deficiencies and those experiencing major haemorrhage.

Every one of these units comes from a voluntary unpaid donor who chose to give approximately an hour of their time. There is no industrial production line, no laboratory synthesis and no government programme that can replace this. The entire supply of blood in the UK rests on the decision of individual members of the public to donate voluntarily.

There is no substitute for human blood

Despite decades of research into artificial blood substitutes and oxygen carriers, no product has been approved for routine clinical use that can replace the full functionality of human blood. Red blood cell substitutes have shown limited promise in specific trauma contexts but none are in routine clinical use in the UK. The complexity of blood, its clotting factors, immune components, oxygen-carrying capacity and compatibility requirements, cannot be replicated by any manufactured product.

This means the NHS is entirely dependent on human donors. A shortfall in donation has direct and immediate clinical consequences. Elective surgery is postponed when blood stocks fall. Cancer patients may receive delayed treatment. Trauma teams operate with reduced margins. The dependency is total and permanent with current medical technology.

Who needs donated blood and why

Blood is needed across almost every specialty in medicine. Cancer patients undergoing chemotherapy often require regular platelet and red cell transfusions because treatment suppresses the bone marrow's ability to produce its own blood cells. Patients having major surgery, including cardiac surgery, liver transplants and orthopaedic procedures, require significant blood supplies. Women experiencing postpartum haemorrhage after childbirth depend on rapid transfusion to survive.

People with sickle cell disease require regular red blood cell transfusions to manage their condition throughout their lives. Trauma patients arrive in emergency departments having lost large volumes of blood and need immediate transfusion to survive. Premature babies may need transfusions of just millilitres of highly compatible blood. The range of patients who depend on donated blood spans every age group and every branch of medicine.

The ongoing shortfall in donor numbers

The UK needs approximately 135,000 new blood donors every year simply to replace those who stop donating due to age, health changes or changes in circumstances. Total donor numbers have declined over several decades as the population has aged and lifestyle changes have made regular donation less habitual for newer generations.

Certain blood types, particularly O negative, are consistently below safe stock levels. Platelets, with their five-to-seven-day shelf life, require constant replenishment. The donor base needs not only to be maintained but to grow as the NHS population it serves ages and as the number of patients requiring transfusion increases with the growing burden of cancer and other chronic diseases.

Why diverse donors matter specifically

The UK population is increasingly ethnically diverse, and some blood conditions that require regular transfusion, particularly sickle cell disease, are significantly more common in people of African and South Asian heritage. For patients with sickle cell disease who receive frequent transfusions, genetically compatible blood from donors of similar ethnic backgrounds reduces the risk of alloimmunisation, a serious complication where the immune system develops antibodies against donated blood.

The proportion of blood donors from Black, Asian and minority ethnic backgrounds does not yet reflect the proportion of patients from those communities who depend on donated blood. NHS Blood and Transplant actively campaigns to increase donor diversity, particularly among South Asian, Black African and Black Caribbean communities, because the health of patients from those communities depends directly on having donors with matching blood profiles.

What would happen without donors

A collapse in blood donation would create a cascade of clinical failures. Elective surgery including joint replacements, cancer resections and organ transplants would be cancelled. Emergency surgery would become higher risk. Cancer chemotherapy would be delayed or interrupted. Childbirth complications would become more deadly. The NHS would have to ration a resource that is currently available on demand.

This is not a theoretical scenario. During the COVID-19 pandemic, donation sessions were reduced and some services experienced critical stock shortages. The NHS issued urgent national appeals and stocks were eventually replenished by donors responding to those appeals. The episode demonstrated both the fragility of the supply and its dependence on public engagement.